14 August 2020
Results of Placing
14 August 2020
Results of Placing
13 August 2020
Interim Results for the Six Months ended 30 June 2020
02 March 2020
Results for the Year ended 31 December 2019
27 February 2020
Acacia Pharma Announces US FDA Approval of BARHEMSYS® (amisulpride) for the Treatment and Prevention of Postoperative Nausea and Vomiting (PONV)
24 January 2020
Acacia Pharma Wins BEL Small Company of the Year 2019
13 January 2020
Acacia Pharma Announces Planned CFO Succession
10 January 2020
Acacia Pharma Enters into Strategic In-licensing, Investment and Loan Transaction with Cosmo Pharmaceuticals N.V.
05 September 2019
Interim Results for the Six Months ended 30 June 2019
12 July 2019
Editorial on Positive Data for BARHEMSYS® Treatment of PONV Published in Anesthesia & Analgesia
03 June 2019
Annual General Meeting Results and Statement
07 May 2019
Notice of Annual General Meeting
27 February 2019
Results for the year ended 31 December 2018